Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Envista cut to Sell at Goldman Sachs, CRISPR to Underperform: 4 big analyst cuts

Published 12/11/2023, 08:27 AM
© Reuters

Investing.com — Here is your Pro Recap of the biggest analyst cuts you may have missed today: downgrades at Envista, CRISPR Therapeutics, Super Micro Computer, and Vornado Realty Trust.

InvestingPro subscribers got this news first. Never miss another market-moving headline.

Envista slashed to Sell at Goldman Sachs

Envista (NYSE:NVST) shares dropped more than 2% pre-market today after Goldman Sachs downgraded the company to Sell from Neutral with a price target of $22.00.

According to the analysts, the downgrade is driven by concerns about Envista's product positioning in implants and equipment, a perceived lack of innovation in its pipeline, and competitive pressures. They believe these factors may hinder Envista's ability to quickly re-accelerate growth towards its mid-single digit to high-single digit target and achieve margin expansion.

The analysts noted that the dental industry is entering 2024 amidst uncertain market conditions, marked by a decline in patient traffic, elective demand, and capital expenditures in dental practices in the second half of 2023. “Beyond current macro conditions, we see headwinds to longer run growth from limited product innovation, ASP pressure in equipment, and challenging competitive dynamics in implants and clear aligners,” commented Goldman Sachs.

CRISPR Therapeutics cut at TD Cowen

TD Cowen downgraded Crispr Therapeutics (NASDAQ:CRSP) to Underperform from Market Perform with a price target of $30.00, as reported in real-time on InvestingPro.

While acknowledging last week’s FDA approval of Casgevy as a significant scientific achievement for gene editing, the analysts expressed skepticism about its broad application. They suggest that the current high valuation of CRISPR Therapeutics is largely due to a recent aggressive short squeeze rather than fundamental market factors.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro | Outsmart the Market

Two more downgrades

Susquehanna downgraded Super Micro Computer (NASDAQ:SMCI) to Negative from Neutral with a price target of $160.00. Shares fell more than 2% pre-market today.

The downgrade is primarily due to increased gross margin pressure arising from heightened competition and rising costs for Memory/Storage. Additionally, the diversification in server architecture, especially for AI applications, necessitates higher inventories to accommodate a wider range of stock-keeping units (SKUs) for each configuration.

Our estimate change and downgrade is based on industry fundamentals. We applaud SuperMicro's strategy of enabling mass customization of next gen server architecture, including AI Servers. However, consistent with our industry view and recent checks from throughout the supply chain, there are several factors that have led to estimate reduction.

Vornado Realty Trust (NYSE:VNO) shares fell more than 1% pre-market today after Evercore ISI downgraded the company to Underperform from In Line with a price target of $28.00 (from $23.00).

Amid whipsaw markets and a slew of critical headlines, seize on the right timing to protect your profits: Always be the first to know with InvestingPro.

InvestingPro | Be The First To Know

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.